Search for Clinical Trial Results
Focal Segmental Glomerulosclerosis - 27 Studies Found
Status | Study |
Recruiting |
Study Name: Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis Condition:
|
Recruiting |
Study Name: Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS Condition: Idiopathic Focal Segmental Glomerulosclerosis Date: 2015-12-15 Interventions:
|
Withdrawn |
Study Name: Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis Condition: Focal Glomerulosclerosis Date: 2006-03-13 Interventions: Drug: Tacrolimus Tacrolimus Other Name: Tacrolimus, |
Completed |
Study Name: Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS) Condition: Focal Glomerulosclerosis Date: 2005-09-10 Interventions:
|
Completed |
Study Name: Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft Condition: Glomerulosclerosis, Focal Date: 2006-07-17 Interventions: Procedure: Total Lymphoid irradiation |
NOT_YET_RECRUITING |
Study Name: AMPK-activation by Metformin in FSGS: AMP-FSGS Condition: Focal Segmental Glomerulosclerosis Date: 2024-05-17 Interventions: Administration of daily oral extended-release Metformin 500 mg tablets with standard of care for 6 months. |
COMPLETED |
Study Name: A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147 Condition: Focal Segmental Glomerulosclerosis (FSGS) Date: 2024-05-17 Interventions: Tablets for oral administration. |